Skip to main content

Peer Review reports

From: Role of delayed salvage bevacizumab at symptomatic progression of chemorefractory glioblastoma

Original Submission
1 Jul 2018 Submitted Original manuscript
19 Jul 2018 Author responded Author comments - Moira Cuncannon
Resubmission - Version 2
19 Jul 2018 Submitted Manuscript version 2
15 Aug 2018 Reviewed Reviewer Report - Gaetano Finocchiaro
27 Aug 2018 Reviewed Reviewer Report - Quintino Giorgio D'Alessandris
9 Oct 2018 Author responded Author comments - Moira Cuncannon
Resubmission - Version 3
9 Oct 2018 Submitted Manuscript version 3
28 Oct 2018 Reviewed Reviewer Report - Quintino Giorgio D'Alessandris
2 Nov 2018 Reviewed Reviewer Report - Gaetano Finocchiaro
29 Nov 2018 Author responded Author comments - Moira Cuncannon
Resubmission - Version 4
29 Nov 2018 Submitted Manuscript version 4
21 Dec 2018 Reviewed Reviewer Report - Reviewer 2
12 Mar 2019 Author responded Author comments - Moira Cuncannon
Resubmission - Version 5
12 Mar 2019 Submitted Manuscript version 5
27 Mar 2019 Reviewed Reviewer Report - Reviewer 2
11 Apr 2019 Reviewed Reviewer Report - Maurizio MARTINI
13 Apr 2019 Author responded Author comments - Moira Cuncannon
Resubmission - Version 6
13 Apr 2019 Submitted Manuscript version 6
24 Apr 2019 Author responded Author comments - Moira Cuncannon
Resubmission - Version 7
24 Apr 2019 Submitted Manuscript version 7
Publishing
3 May 2019 Editorially accepted
14 May 2019 Article published 10.1186/s12885-019-5678-1

You can find further information about peer review here.

Back to article page